Wriver Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 1 Year 8 Months
- Open Charges ₹ 26.95 Cr
About Wriver Life Sciences
Wriver Life Sciences Private Limited (WLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 May 2023 (One year and eight months 18 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹26.95 Cr.
Parmod Kumar, Nitesh Agrawal, and Manish Agarwal serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U23935RJ2023PTC087707
-
Company No.
087707
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 May 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Wriver Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parmod Kumar
|
Additional Director | 08-Feb-2024 | Current |
|
Nitesh Agrawal
|
Director | 17-May-2023 | Current |
|
Manish Agarwal
|
Director | 17-May-2023 | Current |
Financial Performance of Wriver Life Sciences.
Enhance accessibility to Wriver Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wriver Life Sciences?
Unlock access to Wriver Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Maxhill Pharmaceutical Private LimitedParmod Kumar is a mutual person
-
Kihaa Foods And Hospitality Private Limited
Nitesh Agrawal and Manish Agarwal are mutual person
-
Kihaa Laboratories (Opc) Private Limited
Nitesh Agrawal is a mutual person
-
Mediclus Lifesciences Private Limited
Nitesh Agrawal is a mutual person
-
Gkhk Foods Private Limited
Manish Agarwal is a mutual person
Charges (Loans)
₹26.95 Cr
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 26.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2024 | Sidbi | ₹26.95 Cr | Open |
How Many Employees Work at Wriver Life Sciences?
Unlock and access historical data on people associated with Wriver Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wriver Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wriver Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.